{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:18:56Z","timestamp":1792063136462,"version":"4.4.0"},"publisher-location":"Totowa, NJ","reference-count":23,"publisher":"Humana Press","isbn-type":[{"value":"9781627033565","type":"print"},{"value":"9781627033572","type":"electronic"}],"license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/978-1-62703-357-2_8","type":"book-chapter","created":{"date-parts":[[2013,4,8]],"date-time":"2013-04-08T19:16:08Z","timestamp":1365448568000},"page":"123-136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Flow Cytometric Monitoring of Residual Disease in Acute Leukemia"],"prefix":"10.1007","author":[{"given":"Brent L.","family":"Wood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,7]]},"reference":[{"key":"8_CR00081","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S0091-679X(04)75023-2","volume":"75","author":"BL Wood","year":"2004","unstructured":"Wood BL (2004) Multicolor immunophenotyping: human immune system hematopoiesis. Methods Cell Biol 75:559\u2013576","journal-title":"Methods Cell Biol"},{"key":"8_CR00082","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.1182\/blood-2007-11-120535","volume":"111","author":"FE Craig","year":"2008","unstructured":"Craig FE, Foon KA (2008) Flow cytometry immunophentoyping for hematopoietic neoplasms. Blood 111:3941\u20133967","journal-title":"Blood"},{"key":"8_CR00083","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S1521-6926(03)00067-7","volume":"16","author":"MB Vidriales","year":"2003","unstructured":"Vidriales MB, San-Miguel JF, Orfao A, Coustan-Smith E, Campana D (2003) Minimal residual disease monitoring by flow cytometry. Best Pract Res Clin Haematol 16:599\u2013612","journal-title":"Best Pract Res Clin Haematol"},{"key":"8_CR00084","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/sj.leu.2401364","volume":"13","author":"EG Weir","year":"1999","unstructured":"Weir EG, Cowan K, LeBeau P, Borowitz MJ (1999) A limited antibody panel can distinguish B-precursor acute lymphoblastic leukemia from normal B precursors with four color flow cytometry: implications for residual disease detection. Leukemia 13:558\u2013567","journal-title":"Leukemia"},{"key":"8_CR00085","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1309\/FY0UMAMM91VPMR2W","volume":"129","author":"A Al-Mawali","year":"2008","unstructured":"Al-Mawali A, Gillis D, Hissaria P, Lewis I (2008) Incidence, sensitivity, and specificity of leukemia-associated phenotypes in acute myeloid leukemia using specific five-color multiparameter flow cytometry. Am J Clin Pathol 129:934\u2013945","journal-title":"Am J Clin Pathol"},{"key":"8_CR00086","doi-asserted-by":"crossref","first-page":"680","DOI":"10.5858\/2006-130-680-CACFCI","volume":"130","author":"B Wood","year":"2006","unstructured":"Wood B (2006) 9 and 10 color flow cytometry in the clinical laboratory. Arch Pathol Lab Med 130:680\u2013690","journal-title":"Arch Pathol Lab Med"},{"key":"8_CR00087","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.1182\/blood-2010-12-324004","volume":"117","author":"E Coustan-Smith","year":"2011","unstructured":"Coustan-Smith E, Song G, Clark C, Key L, Liu P, Mehrpooya M et al (2011) New markers for minimal residual disease detection in acute lymphoblastic leukemia. Blood 117:6267\u20136276","journal-title":"Blood"},{"key":"8_CR00088","doi-asserted-by":"publisher","first-page":"5477","DOI":"10.1182\/blood-2008-01-132837","volume":"111","author":"MJ Borowitz","year":"2008","unstructured":"Borowitz MJ, Devidas M, Hunger SP, Bowman WP, Carroll AJ, Carroll WL et al (2008) Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children\u2019s Oncology Group study. Blood 111:5477\u20135485","journal-title":"Blood"},{"key":"8_CR00089","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1182\/blood-2005-07-2708","volume":"107","author":"German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia","year":"2006","unstructured":"Bruggemann M, Raff T, Flohr T, G\u00f6kbuget N, Nakao M, Droese J et al German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia (2006) Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia. Blood 107:1116\u20131123","journal-title":"Blood"},{"key":"8_CR000810","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1046\/j.1365-2141.2003.03974.x","volume":"120","author":"M Krampera","year":"2003","unstructured":"Krampera M, Vitale A, Vincenzi C, Perbellini O, Guarini A, Annino L et al (2003) Outcome prediction by immunophenotypic minimal residual disease detection in adult T-cell acute lymphoblastic leukaemia. Br J Haematol 120:74\u201379","journal-title":"Br J Haematol"},{"key":"8_CR000811","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1038\/sj.leu.2403001","volume":"17","author":"Children\u2019s Oncology Group study","year":"2003","unstructured":"Borowitz MJ, Pullen DJ, Shuster JJ, Viswanatha D, Montgomery K, Willman CL et al Children\u2019s Oncology Group study (2003) Minimal residual disease detection in childhood precursor-B-cell acute lymphoblastic leukemia: relation to other risk factors. A Children\u2019s Oncology Group study. Leukemia 17:1566\u20131572","journal-title":"Leukemia"},{"key":"8_CR000812","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/sj.leu.2402736","volume":"17","author":"E Bjorklund","year":"2003","unstructured":"Bjorklund E, Mazur J, Soderhall S, Porwit-MacDonald A (2003) Flow cytometric follow-up of minimal residual disease in bone marrow gives prognostic information in children with acute lymphoblastic leukemia. Leukemia 17:138\u2013148","journal-title":"Leukemia"},{"key":"8_CR000813","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1182\/blood.V99.6.1952","volume":"99","author":"Austrian Berlin-Frankfurt-M\u00fcnster Study Group","year":"2002","unstructured":"Dworzak MN, Froschl G, Printz D, Mann G, P\u00f6tschger U, M\u00fchlegger N et al Austrian Berlin-Frankfurt-M\u00fcnster Study Group (2002) Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia. Blood 99:1952\u20131958","journal-title":"Blood"},{"key":"8_CR000814","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1182\/blood.V96.8.2691","volume":"96","author":"E Coustan-Smith","year":"2000","unstructured":"Coustan-Smith E, Sancho J, Hancock ML, Boyett JM, Behm FG, Raimondi SC et al (2000) Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. Blood 96:2691\u20132696","journal-title":"Blood"},{"key":"8_CR000815","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/cyto.b.20444","volume":"76","author":"A Al-Mawali","year":"2009","unstructured":"Al-Mawali A, Gillis D, Lewis I (2009) The use of receiver operating characteristic analysis for detection of minimal residual disease using five-color multiparameter flow cytometry in acute myeloid leukemia identifies patients with high risk of relapse. Cytometry B Clin Cytom 76:91\u2013101","journal-title":"Cytometry B Clin Cytom"},{"key":"8_CR000816","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1182\/blood-2004-03-1036","volume":"104","author":"W Kern","year":"2004","unstructured":"Kern W, Voskova D, Schoch C, Hiddemann W, Schnittger S, Haferlach T (2004) Determination of relapse risk based on assessment of minimal residual disease during complete remission by multiparameter flow cytometry in unselected patients with acute myeloid leukemia. Blood 104:3078\u20133085","journal-title":"Blood"},{"key":"8_CR000817","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1038\/sj.leu.2404313","volume":"20","author":"F Buccisano","year":"2006","unstructured":"Buccisano F, Maurillo L, Gattei V, Del Poeta G, Del Principe MI, Cox MC et al (2006) The kinetics of reduction of minimal residual disease impacts on duration of response and survival of patients with acute myeloid leukemia. Leukemia 20:1783\u20131789","journal-title":"Leukemia"},{"key":"8_CR000818","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1182\/blood.V98.6.1746","volume":"98","author":"JF San Miguel","year":"2001","unstructured":"San Miguel JF, Vidriales MB, L\u00f3pez-Berges C, D\u00edaz-Mediavilla J, Guti\u00e9rrez N, Ca\u00f1izo C et al (2001) Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification. Blood 98:1746\u20131751","journal-title":"Blood"},{"key":"8_CR000819","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/cyto.b.20138","volume":"70","author":"BL Wood","year":"2006","unstructured":"Wood BL, Levin GR (2006) Interactions between mouse IgG2 antibodies are common and mediated by plasma C1q. Cytometry B Clin Cytom 70:321\u2013328","journal-title":"Cytometry B Clin Cytom"},{"key":"8_CR000820","doi-asserted-by":"crossref","unstructured":"Gaipa G, Basso G, Aliprandi S, Migliavacca M, Vallinoto C, Maglia O et al I-BFM-ALL-FCM-MRD-Study Group (2008) Prednisone induces immunophenotypic modulation of CD10 and CD34 in nonapoptotic B-cell precursor acute lymphoblastic leukemia cells. Cytometry B Clin Cytom. 74:150\u20135","DOI":"10.1002\/cyto.b.20408"},{"key":"8_CR000821","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/cyto.b.20071","volume":"68","author":"MJ Borowitz","year":"2005","unstructured":"Borowitz MJ, Pullen DJ, Winick N, Martin PL, Bowman WP, Camitta B (2005) Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: implications for residual disease detection: a report from the Children\u2019s Oncology Group. Cytometry B Clin Cytom 68:18\u201324","journal-title":"Cytometry B Clin Cytom"},{"key":"8_CR000822","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1182\/blood.V97.11.3574","volume":"97","author":"MR Baer","year":"2001","unstructured":"Baer MR, Stewart CC, Dodge RK, Leget G, Sul\u00e9 N, Mr\u00f3zek K et al (2001) High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361). Blood 97:3574\u20133580","journal-title":"Blood"},{"key":"8_CR000823","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cyto.b.20037","volume":"63","author":"C Langebrake","year":"2005","unstructured":"Langebrake C, Brinkmann I, Teigler-Schlegel A, Creutzig U, Griesinger F, Puhlmann U et al (2005) Immunophenotypic differences between diagnosis and relapse in childhood AML: implications for MRD monitoring. Cytometry B Clin Cytom 63:1\u20139","journal-title":"Cytometry B Clin Cytom"}],"container-title":["Methods in Molecular Biology","Hematological Malignancies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-62703-357-2_8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T11:39:35Z","timestamp":1676806775000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-62703-357-2_8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"ISBN":["9781627033565","9781627033572"],"references-count":23,"URL":"https:\/\/doi.org\/10.1007\/978-1-62703-357-2_8","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]},"assertion":[{"value":"7 March 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}